IP Library › Granted Patent US 10,251,703
Granted Patent B2
US 10,251,703 · App. 15/607,688 · Granted Apr 9, 2019

Nerve sparing treatment systems and methods

Inventors: Dan David Albeck (Givat Shmuel, IL); Tzachi Itzhak Sabati (Megadim, IL)
Assignee: NERVESENSE LTD.
A61B18/22A61B5/4836A61B5/4893A61N5/0622A61B18/1492A61B18/1815A61B2017/00039A61B2017/00119A61B2017/00176A61B2018/0066A61B2018/00339A61B2018/00547A61B2018/00577A61B2018/00642A61B2018/00702A61B2018/00708A61B2018/00732A61B2018/00839A61B2018/00898A61B2018/00904
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,251,703
App. No.
15/607,688
Granted
Apr 9, 2019
Kind
B2
Abstract

Treatment systems are provided, which comprise a treatment element applying a treatment to a tissue, a stimulation element optically stimulating nerves in the tissue, a sensing unit sensing an electrical signal produced by nerves in the tissue in response to the optical stimulation, and a control unit controlling the application of the treatment according to the sensed signal. The systems and methods are used to avoid damaging nerves by sensing them during operation and immediately before local treatment application and preventing energy emission when the treatment tool is too close to specified nerves. Additional electric stimulation may be provided to enable avoidance of nerve damages on a larger scale, the treatment may be applied by a cold laser, and the control unit may control the treatment in realtime and in a closed loop and immediate prevent further treatment upon sensing optically stimulated nerves.

Claims (20)

1. A treatment probe comprising:

a single probe including:

a surgical treatment tool having a distal end located at a tip of the probe, and configured to treat a tissue, including to cut, ablate or coagulate the tissue;

a non-ablative infrared laser comprising an optical fiber configured to send an optical stimulation beam from the tip of the probe to stimulate nerves in the tissue;

at least one non-contact electric field or magnetic field sensing antenna positioned at a distance of 5 cm or more proximally to the tip of the probe, surrounding the probe and configured to remotely sense an electrical signal produced by the nerves in the tissue without direct contact with the tissue, in response to the optical stimulation beam; and

a control unit configured to:

control the non-ablative laser to apply the optical stimulation beam;

sense, in real time, by the at least one non-contact electric field or magnetic field sensing antenna, if the electrical signal was produced by the nerves in the tissue; and

control, in real-time, the treatment tool to treat the tissue if no signal was sensed by the non-contact electric field or magnetic field sensing antenna; and

prevent, in real-time, the treatment tool from treating the tissue if a signal was sensed by the non-contact electric field or magnetic field sensing antenna.

2. The treatment probe of claim 1 , wherein the cutting tool comprises one selected from the group consisting of: an ablative laser cutting tool comprising an optical fiber, a radiofrequency electromagnetic radiation (RF) cutting device and microwave radiation cutting device.

3. The treatment probe of claim 1 , wherein the control unit is further configured to immediately prevent treatment application upon sensing, by the non-contact electric sensing antenna, the signal produced by the nerves.

4. The treatment probe of claim 1 , wherein the control unit is further configured to:

apply a plurality of treatment cycles at a frequency of at least 1 Hz, wherein each treatment cycle from the plurality of treatment cycles comprises:

applying the optical stimulation signal;

sensing if an electrical signal was produced by the nerves in the tissue; and

applying the treatment to the tissue if no signal was sensed.

5. The treatment probe of claim 4 , wherein the frequency is at least 10 Hz.

6. The treatment probe of claim 4 , wherein the frequency is at least 400 Hz.

7. The treatment probe of claim 1 , wherein the single probe further accommodates an electric stimulation electrode, configured to send an electric stimulation signal to the tissue from the tip of the probe, and wherein an additional electric sensing electrode is further configured to sense an electrical signal produced by the nerves in the tissue in response to the electrical stimulation signal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2019
From: ALBECK, DAN DAVID; SABATI, TZACHI ITZHAK
To: NERVESENSE LTD.
Reel/Frame 048461/0061 →
Continuity (2)
Continuation 14191446 · Feb 27, 2014
Related Publication 20170348052A1 · Dec 7, 2017
Cited By (1)
US 12,201,356